Home » Topics » BioWorld Science

BioWorld Science
RSS

Missense variants in DDX39B linked to novel syndrome of global neurodevelopmental delay

March 28, 2022

Sosei Heptares' GLP-1/2 agonist HTL-0030023 shows promising results for treating NAFLD and NASH

March 28, 2022

Novartis details discovery, preclinical data of novel antimalarial compound INE-963

March 28, 2022

Novel USP30 inhibitors as potential anti-Parkinson candidates

March 28, 2022

Bayer patents P2X purinoceptor 4 antagonists

March 28, 2022

Dompe Farmaceutici describes new peptides with angiogenic activity

March 28, 2022

HDAC inhibitors disovered at Chong Kun Dang Pharmaceutical

March 28, 2022

Yale University divulges new oligosaccharyltransferase complex inhibitors

March 28, 2022

New antibacterials identified at Roche

March 28, 2022

Phosphatidylserine is crucial for synaptic pruning in adult-born neurons

March 28, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Atai Therapeutics patents new 5-HT2 receptor agonists
BioWorld Science
Atai Therapeutics Inc. has identified new 5-HT2 receptor agonists potentially useful for the treatment of psychiatric disorders.